US-based Thermo Fisher Scientific has announced the launch of the Thermo Scientific Multiskan Ease Absorbance Microplate...
ENA Respiratory, a clinical-stage pharmaceutical startup developing host defence enhancers for the prevention of complic...
Japan-based Ono Pharmaceutical has entered into a drug discovery partnership agreement with US-based Aitia, Inc. Under t...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
South Korea-based Samsung Bioepis has announced the marketing approval of Ustekinumab BS Intravenous Infusion 130mg...
South Korea based Alteogen Inc. has entered into an option and license agreement with Novartis for the development and c...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...
Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that th...
South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
DKSH has signed an agreement to acquire P.R. Chemicals, a specialties distributor of Active Pharmaceutical Ingredients (...
US-based Celularity Inc., a longevity-focused regenerative and cellular medicine company, and Singaporean startup M...
Cytrellis Biosystems, Inc., a medical aesthetics company bridging the gap in skin health and restoration, has annou...
Japan-based PENTAX Medical, a HOYA Group company, has announced the expansion of its partnership with MAGENTIQ EYE, exte...
Japan-based Shimadzu Corporation has invested in OptQC Inc., a startup originating from The University of Tokyo, through...
US-based Biohaven and SK Biopharmaceuticals, based in South Korea, have announced a strategic global licensing and ...
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...
US-based Advent, a leading global private equity investor, has signed a definitive agreement to acquire a majority share...
GC Biopharma, a leading global pharmaceutical company based in South Korea, has announced that its Hunter syndrome treat...
South Korea-based Hanmi Pharm has entered into an exclusive licensing agreement with Genentech, a member of the Roche Gr...
Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
Taiwan-based Lotus Pharmaceutical Co. has announced a strategic licensing and commercialisation agreement with Alvotech,...
South Korea based Rznomics Inc, a biopharmaceutical company specialising in the development of RNA-based gene therapies,...
